Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
also be used for arrang<strong>in</strong>g the next dose<br />
<strong>of</strong> hepar<strong>in</strong>. Over dosage <strong>of</strong> hepar<strong>in</strong> can<br />
be easily reversed by giv<strong>in</strong>g protam<strong>in</strong>e<br />
sup late 1 mg per 1000 units <strong>of</strong> hepar<strong>in</strong>.<br />
Hepar<strong>in</strong>:<br />
Sulph ated carbohydrate: Different size<br />
bov<strong>in</strong>e lungs, Adm<strong>in</strong>istration parenteral<br />
do not <strong>in</strong>ject IM - only IV or deep S.C.<br />
Half-life 1 - 5 hrs - monitor aPTT.<br />
Adverse effect: hemorrhage Anti-dote:<br />
protam<strong>in</strong>e sulphate.<br />
Oral anticoagulants:<br />
Examples: Coumar<strong>in</strong>s - warfar<strong>in</strong>,<br />
dicumarol, structurally related to vitam<strong>in</strong><br />
K, Inhibits production <strong>of</strong> active clott<strong>in</strong>g<br />
factors, Clearance is slow - 36 hrs,<br />
Delayed onset 8 - 12 hrs overdose -<br />
reversed by vitam<strong>in</strong> K <strong>in</strong>fusion and can<br />
cross placenta - do not use dur<strong>in</strong>g late<br />
pregnancies.<br />
Mechanism <strong>of</strong> action:<br />
Normally, vitam<strong>in</strong> K is converted to<br />
vitam<strong>in</strong> K epoxide <strong>in</strong> the liver. This<br />
epoxide is then reduced by the enzyme<br />
epoxide reductase. The reduced form <strong>of</strong><br />
vitam<strong>in</strong> K epoxide is necessary for the<br />
synthesis <strong>of</strong> many coagulation factors (II,<br />
VII, IX and X, as well as prote<strong>in</strong> C and<br />
prote<strong>in</strong> S). Warfar<strong>in</strong> <strong>in</strong>hibits the enzyme<br />
epoxide reductase the liver, thereby<br />
<strong>in</strong>hibit<strong>in</strong>g coagulation.<br />
Warfar<strong>in</strong> side effect:<br />
Severe Side effects: Severe bleed<strong>in</strong>g<br />
from the rectum or black stool Sk<strong>in</strong><br />
conditions such as hives, a rash or<br />
itch<strong>in</strong>g. Swell<strong>in</strong>g <strong>of</strong> the face, throat,<br />
mouth, legs, feet or hands, bruis<strong>in</strong>g that<br />
comes about without an <strong>in</strong>jury you<br />
140<br />
remember, Chest pa<strong>in</strong> or pressure<br />
Nausea or vomit<strong>in</strong>g, fever or flulike<br />
symptoms. Jo<strong>in</strong>t or muscle aches<br />
diarrhea, difficulty mov<strong>in</strong>g Numbness <strong>of</strong><br />
t<strong>in</strong>gl<strong>in</strong>g <strong>in</strong> any part <strong>of</strong> your body and<br />
Pa<strong>in</strong>ful erection last<strong>in</strong>g four hours or<br />
longer.<br />
Other less serious warfar<strong>in</strong> side<br />
effects:<br />
Gas, feel<strong>in</strong>g cold, fatigue, pale sk<strong>in</strong><br />
changes <strong>in</strong> the way foods taste and Hair<br />
loss.<br />
Drug <strong>in</strong>teraction with warfar<strong>in</strong>:<br />
Category Mechanism Representati<br />
ve Drugs<br />
Drugs that<br />
Increase<br />
Warfar<strong>in</strong> Activity<br />
Drugs that<br />
promote<br />
bleed<strong>in</strong>g<br />
Warfar<strong>in</strong> activity<br />
Drugs that<br />
decrease<br />
Decrease b<strong>in</strong>d<strong>in</strong>g to<br />
Album<strong>in</strong> <strong>in</strong>hibit<br />
degradation<br />
decrease synthesis <strong>of</strong><br />
clott<strong>in</strong>g Factors<br />
Inhibition <strong>of</strong> platelets<br />
Factors<br />
Inhibition <strong>of</strong> clott<strong>in</strong>g<br />
Promote clott<strong>in</strong>g<br />
factor<br />
Reduced absorption<br />
Synthesis<br />
Aspir<strong>in</strong>,<br />
Sulfonamides<br />
Cimetid<strong>in</strong>e,<br />
Disulfiram<br />
Antibiotics<br />
(oral)<br />
Aspir<strong>in</strong><br />
hepar<strong>in</strong><br />
antimetabolit<br />
es<br />
Vitam<strong>in</strong> K<br />
Colestipol<br />
Cholestyrami<br />
ne<br />
Naphthoqu<strong>in</strong>one - This group <strong>of</strong> drugs<br />
<strong>in</strong>clude dicoumarol, and phen<strong>in</strong>dione.<br />
These drugs are chemically similar to<br />
Vitam<strong>in</strong> K. They act by replac<strong>in</strong>g<br />
Vitam<strong>in</strong> K at the site <strong>of</strong> prothromb<strong>in</strong><br />
formation. They also prevent the hepatic<br />
synthesis <strong>of</strong> factor VII, IX and X. The<br />
anticoagulant effect <strong>of</strong> hepar<strong>in</strong> is<br />
immediate and maximal after<br />
<strong>in</strong>travenous <strong>in</strong>jection, but decreases<br />
rapidly over the course <strong>of</strong> few hours.<br />
The effect <strong>of</strong> oral anticoagulants on the<br />
other hand, is negligible for the first 24